These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 16550003

  • 1. In-vitro schedule-dependent interaction between oxaliplatin and 5-fluorouracil in human gastric cancer cell lines.
    Qin B, Tanaka R, Shibata Y, Arita S, Ariyama H, Kusaba H, Baba E, Harada M, Nakano S.
    Anticancer Drugs; 2006 Apr; 17(4):445-53. PubMed ID: 16550003
    [Abstract] [Full Text] [Related]

  • 2. In vitro schedule-dependent interaction between paclitaxel and oxaliplatin in human cancer cell lines.
    Tanaka R, Ariyama H, Qin B, Takii Y, Baba E, Mitsugi K, Harada M, Nakano S.
    Cancer Chemother Pharmacol; 2005 Jun; 55(6):595-601. PubMed ID: 15731917
    [Abstract] [Full Text] [Related]

  • 3. In vitro sequence-dependent interaction between nedaplatin and paclitaxel in human cancer cell lines.
    Tanaka R, Takii Y, Shibata Y, Ariyama H, Qin B, Baba E, Kusaba H, Mitsugi K, Harada M, Nakano S.
    Cancer Chemother Pharmacol; 2005 Sep; 56(3):279-85. PubMed ID: 15875187
    [Abstract] [Full Text] [Related]

  • 4. Schedule-dependent synergistic interaction between gemcitabine and oxaliplatin in human gallbladder adenocarcinoma cell lines.
    Makiyama A, Qin B, Uchino K, Shibata Y, Arita S, Isobe T, Hirano G, Kusaba H, Baba E, Akashi K, Nakano S.
    Anticancer Drugs; 2009 Feb; 20(2):123-30. PubMed ID: 19209029
    [Abstract] [Full Text] [Related]

  • 5. Potentiation of apoptosis by flavopiridol in mitomycin-C-treated gastric and breast cancer cells.
    Schwartz GK, Farsi K, Maslak P, Kelsen DP, Spriggs D.
    Clin Cancer Res; 1997 Sep; 3(9):1467-72. PubMed ID: 9815832
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effects of 5-fluouracil combined with sulfasalazine on human pancreatic carcinoma cell line BxPC-3 proliferation and apoptosis in vitro.
    Huang Z, Guo KJ, Guo RX, He SG.
    Hepatobiliary Pancreat Dis Int; 2007 Jun; 6(3):312-20. PubMed ID: 17548258
    [Abstract] [Full Text] [Related]

  • 9. Anti-tumor activity of heptaplatin in combination with 5-fluorouracil or paclitaxel against human head and neck cancer cells in vitro.
    Lee JW, Park JK, Lee SH, Kim SY, Cho YB, Kuh HJ.
    Anticancer Drugs; 2006 Apr; 17(4):377-84. PubMed ID: 16549994
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Intermittent FLDP: 24-h infusion of 5-FU on days 1, 3 and 5 combined with low-dose cisplatin on days 1-5 for gastric cancer, and its pharmacologic and kinetic rationale.
    Terashima M, Irinoda T, Kawamura H, Takagane A, Abe K, Oyama K, Fujiwara H, Saito K, Gotoh M, Shirasaka T.
    Cancer Chemother Pharmacol; 2003 Mar; 51(3):240-6. PubMed ID: 12655443
    [Abstract] [Full Text] [Related]

  • 12. The evaluation of gastric cancer sensitivity to 5-FU/CDDP in terms of induction of apoptosis: time- and p53 expression-dependency of anti-cancer drugs.
    Matsuhashi N, Saio M, Matsuo A, Sugiyama Y, Saji S.
    Oncol Rep; 2005 Sep; 14(3):609-15. PubMed ID: 16077963
    [Abstract] [Full Text] [Related]

  • 13. Sequence-dependent administration of 5-fluorouracil maintains methotrexate antineoplastic activity in human estrogen-negative breast cancer and protects against methotrexate cytotoxicity in human bone marrow.
    Das JR, Fryar-Tita EB, Zhou Y, Green S, Southerland WM, Bowen D.
    Anticancer Res; 2007 Sep; 27(6B):3791-9. PubMed ID: 18225534
    [Abstract] [Full Text] [Related]

  • 14. Cell cycle arrest by oxaliplatin on cancer cells.
    William-Faltaos S, Rouillard D, Lechat P, Bastian G.
    Fundam Clin Pharmacol; 2007 Apr; 21(2):165-72. PubMed ID: 17391289
    [Abstract] [Full Text] [Related]

  • 15. Identifying mechanisms of chronotolerance and chronoefficacy for the anticancer drugs 5-fluorouracil and oxaliplatin by computational modeling.
    Altinok A, Lévi F, Goldbeter A.
    Eur J Pharm Sci; 2009 Jan 31; 36(1):20-38. PubMed ID: 19041394
    [Abstract] [Full Text] [Related]

  • 16. Treatment schedule-dependent effect of 5-fluorouracil and platinum derivatives in colorectal cancer cells.
    Takara K, Fujita M, Minegaki T, Yamamoto K, Takahashi M, Yokoyama T, Okumura K.
    Eur J Pharm Sci; 2012 Feb 14; 45(3):272-81. PubMed ID: 22155546
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.